New Study Suggests CBD May Help Slow Alzheimer’s Disease
A recent study has shed light on the potential benefits of cannabidiol (CBD) in reducing brain inflammation linked to Alzheimer’s disease. Researchers found that inhaled CBD lowered markers of inflammation in mice with Alzheimer’s-like symptoms, particularly in a brain region involved in memory and learning.
The study, published in the journal eNeuro, investigated whether CBD could disrupt neuroinflammation, a persistent immune response in the brain that can damage neurons and accelerate the progression of Alzheimer’s. The researchers used a mouse model of Alzheimer’s disease and gave the mice inhaled CBD daily for four weeks.
The results showed that CBD may modulate markers in two lesser-known inflammatory pathways that may contribute to Alzheimer’s. These pathways, the indoleamine 2,3-dioxygenase (IDO) pathway and the cyclic GMP-AMP synthase (cGAS) pathway, can drive excessive inflammation in the brain and may play a role in the progression of the disease.
The study’s findings suggest that CBD may help alleviate inflammation in the brain, which plays a key role in the progression of Alzheimer’s. While the study is promising, experts caution that the results are preliminary and do not support using cannabis to treat Alzheimer’s. More human studies are needed to determine the efficacy and safety of CBD in treating the disease.
The researchers used 10 mg of inhaled CBD per mouse each day, which cannot be directly converted into a safe or effective dose for humans. The study also only tested one CBD dosage, so it cannot determine the minimum effective dose or establish a safe upper limit.
Cannabis use carries risks, especially for older adults and people already experiencing cognitive changes. THC, the compound responsible for the intoxicating effects of cannabis, can impair memory, attention, balance, reaction time, and judgment, increasing the risk of falls, accidents, and confusion.
Experts emphasize that protecting brain health is about supporting overall health, rather than relying on any single supplement or compound. While the study is scientifically interesting, it is not a recommendation for people with memory loss to start cannabis without medical supervision.
In conclusion, the study suggests that CBD may help slow Alzheimer’s disease by reducing brain inflammation, but more research is needed to determine its efficacy and safety in humans. It is essential to prioritize overall health and well-being, rather than relying on any single compound or supplement, to reduce the risk of developing Alzheimer’s disease.
